Covered recipient · General Payments record
DIANA R LESZCZEWICZ
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$873.88
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $441.83 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $145.26 | 11 |
| Lilly USA, LLC | $72.24 | 4 |
| Corium, Inc. | $71.34 | 4 |
| ITI, Inc. | $33.42 | 2 |
| Alkermes, Inc. | $24.22 | 1 |
| Axsome Therapeutics, Inc. | $20.86 | 1 |
| Otsuka America Pharmaceutical, Inc. | $20.48 | 1 |
| Neurocrine BioSciences, Inc. | $18.74 | 1 |
| Lundbeck LLC | $18.73 | 1 |
| Xeris Pharmaceuticals, Inc. | $16.54 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.59 | 01/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107531599 | CMS |
| ABBVIE INC. | $6.09 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107531601 | CMS |
| ABBVIE INC. | $21.22 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107531603 | CMS |
| ABBVIE INC. | $2.63 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107531605 | CMS |
| ABBVIE INC. | $10.61 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107531607 | CMS |
| ABBVIE INC. | $16.25 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107531609 | CMS |
| ABBVIE INC. | $16.32 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107531611 | CMS |
| ABBVIE INC. | $17.16 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107531613 | CMS |
| ABBVIE INC. | $15.48 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107531615 | CMS |
| ABBVIE INC. | $13.26 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107531617 | CMS |
| ABBVIE INC. | $13.65 | 08/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107531619 | CMS |
| Alkermes, Inc. | $24.22 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120541145 | CMS |
| Axsome Therapeutics, Inc. | $20.86 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148354596 | CMS |
| Corium, LLC | $15.43 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100165237 | CMS |
| Corium, LLC | $19.22 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100175472 | CMS |
| Corium, LLC | $17.93 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100171786 | CMS |
| Corium, LLC | $18.76 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100174200 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.77 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143533498 | CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16.65 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143533500 | CMS |
| Lilly USA, LLC | $17.95 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135617365 | CMS |
| Lilly USA, LLC | $18.95 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135609987 | CMS |
| Lilly USA, LLC | $14.99 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135634608 | CMS |
| Lilly USA, LLC | $20.35 | 07/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135629593 | CMS |
| Lundbeck LLC | $18.73 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146051317 | CMS |
| Neurocrine Biosciences, Inc. | $18.74 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150986189 | CMS |
| Otsuka America Pharmaceutical, Inc. | $20.48 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119121736 | CMS |
| Xeris Pharmaceuticals, Inc. | $16.54 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144624779 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.